+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-08-07Number of Pages: 88

Acute Ischemic Stroke Diagnosis and Treatment Market (By Diagnostics Type - CT, MRI, Ultrasound, Cerebral Angiography, Nuclear Imaging and Others By Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Acute ischemic stroke can be defined as loss of function in certain parts of brain due to lack or disturbance in the blood supply to the brain. This is usually caused by atherosclerosis plaques blocking blood vessels, narrowing of blood vessels, or blood clots closing off blood supply to or from arteries feeding the brain. Technological advancements in surgical devices coupled with rising prevalence of acute ischemia stroke cases collectively accentuates the global demand of surgical procedures in acute stroke treatment. Similarly, aging population, increased demand for minimally invasive procedures and rise in healthcare spending has triggered the growth of this segment market. However, excessive usage of medication for the treatment of ischemic stroke is anticipated to hinder the global market growth of surgery for acute stroke. The global acute ischemic stroke diagnosis and treatment market was valued at USD 1,225.0 million in 2013 and is expected to grow at a CAGR of 6.3% from 2014 to 2020, to reach an estimated value of USD 1,869.7 million by 2020.  

The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnostics type as CT, MRI, ultrasound, cerebral angiography, nuclear imaging and others. In 2013, CT segment accounted for the largest market share of the global acute ischemic stroke diagnosis and treatment market owing to efficient and effective detection, easy availability and strong demand of CT in the global market. Moreover, MRI is expected to grow at the highest CAGR compared with all diagnostic device types during the forecast period due to its increasing popularity. 

In addition, the global market for acute ischemic stroke diagnosis and treatment is segmented based on surgery types as carotid endarterectomy, angioplasty and endovascular mechanical thrombectony. In 2013, carotid endarterectomy accounted for the largest market share and is expected to grow at the highest CAGR in the global acute ischemic stroke surgical treatment market owing to high success rate, easy availability and short treatment duration.  

Geographically, North America was the largest market for acute ischemic stroke diagnosis and treatment in 2013, accounting for the largest share of the acute ischemic stroke diagnosis and treatment market and is expected to grow at a highest CAGR from 2014 to 2020. The acute ischemic stroke diagnosis and treatment market in North America witnessed significant growth due to increasing demand of ischemic stroke products and technological innovations. Moreover, favorable government initiatives have also supported the growth of the acute ischemic stroke diagnosis and treatment market in this region. Europe was the second largest market of the global market in 2013. Rising geriatric population in European Union is one of the major market drivers in this region as geriatric group are more prone to suffer from stroke. 

Asia-Pacific was observed to be a promising market for acute ischemic stroke diagnosis and treatment market during the study period owing to the increasing prevalence of ischemic stroke cases in this region. This region accounted for the third largest share of the global market in 2013 and is estimated to grow at the highest CAGR from 2014 to 2020. Manufacturer of acute ischemic stroke diagnosis and treatment products are expanding their operations in Asian countries (India, China, Japan and South Korea) as these economies hold immense potential for acute ischemic stroke diagnosis and treatment products. For instance, Medtronic Inc, in 2011, established the R&D Shanghai innovation center in China. This facility was established to support further localization in this region. This has helped the company to promote its neurovascular products in emerging countries. Major players operating in the global acute ischemic stroke diagnosis and treatment market includes Covidien plc, Johnson and Johnson, Stryker Corporation and Abbott Laboratories. 

global-acute-ischemic-stroke-diagnosis-and-treatment-market


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Assumptions
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Overview
2.2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2013 & 2020)
2.3 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types , 2013 (USD Million)
2.4 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 and 2020 (Value %)

Chapter 3 Market Overview
3.1 Overview
3.2 Event Impact Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
3.3 Market Drivers
      3.3.1 Rising number of acute stroke patients aiding the growth of diagnosis and treatment market
      3.3.2 Technological innovations in diagnostic and surgical devices boosts market growth
3.4 Restraints
      3.4.1 Alternative treatments and high cost are posing a threat for the growth of the market
3.5 Opportunities
      3.5.1 Huge potential patient in Asia-Pacific creates opportunity for acute ischemic stroke product developers record high growth in revenue
3.6 Value Chain Analysis
3.7 Porter’s Five Force Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
      3.7.1 Bargaining power of suppliers
      3.7.2 Bargaining power of buyers
      3.7.3 Threat of new entrants
      3.7.4 Threat of substitutes
      3.7.5 Competitive rivalry
3.8 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
3.9 Competitive Landscape
      3.9.1 Market Share Analysis by Key Players, 2013 (Value %)

Chapter 4 Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type
4.1 Overview
      4.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2012 – 2020 (USD Million)
4.2 Computed Tomography
      4.2.1 Global Computed Tomography Market Revenue, 2012 – 2020 (USD Million)
4.3 Magnetic Resonance Imaging
      4.3.1 Global Magnetic Resonance Imaging Market Revenue, 2012 – 2020 (USD Million)
4.4 Ultrasound
      4.4.1 Global Ultrasound Market Revenue, 2012 – 2020 (USD Million)
4.5 Cerebral angiography
      4.5.1 Global Cerebral Angiography Market Revenue, 2012 – 2020 (USD Million)
4.6 Nuclear Imaging
      4.6.1 Global Nuclear Imaging Market Revenue, 2012 – 2020 (USD Million)
4.7 Others
      4.7.1 Global Others Market Revenue, 2012 – 2020 (USD Million)

Chapter 5 Acute Ischemic Stroke Diagnosis and Treatment Market by, Surgery Type
5.1 Overview
      5.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2012 – 2020 (USD Million)
5.2 Carotid Endarterectomy
      5.2.1 Global Carotid Endarterectomy Market Revenue, 2012 – 2020 (USD Million)
5.3 Angioplasty
      5.3.1 Global Angioplasty Market Revenue, 2012 – 2020 (USD Million)
5.4 Endovascular Mechanical Thrombectomy
      5.4.1 Global Endovascular Mechanical Thrombectomy Market Revenue, 2012 – 2020 (USD Million)

Chapter 6 Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
6.1 Overview
      6.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million)
6.2 North America
      6.2.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
6.3 Europe
      6.3.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
6.5 Rest of the World
      6.5.1 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)

Chapter 7 Recommendations
7.1 Rigorous research and development initiatives for innovative products
7.2 Investing in emerging economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Covidien plc
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Johnson & Johnson (Cordis Corporation)
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Penumbra, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Philips Healthcare
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 GE Healthcare
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 Hitachi, Ltd.
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Siemens Healthcare
      8.8.1 Company Overview
      8.8.2 Financial overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Stryker Corporation (Concentric Medical, Inc.)
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments

List of Figures

FIG. 1 Acute Ischemic Stroke Diagnosis and Treatment: Market Segmentation
FIG. 2 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Porter’s Five Forces Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market
FIG. 6 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 Value (%)
FIG. 7 Market Share Analysis: Acute Ischemic Stroke Diagnosis and Treatment Market, 2013 (Value %)
FIG. 8 Global Computed Tomography Market Revenue, 2012 – 2020 (USD Million)
FIG. 9 Global Magnetic Resonance Imaging Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Global Ultrasound Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Cerebral Angiography Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global Nuclear Imaging Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global Others Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global Carotid Endarterectomy Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Global Angioplasty Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global Endovascular Mechanical Thrombectomy Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Abbott Laboratories: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 22 Covidien plc: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 23 Johnson & Johnson: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 24 Philips Healthcare: Annual Revenue,2011 – 2013 (USD Million)
FIG. 25 GE Healthcare: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 26 Hitachi, Ltd.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 27 Siemens Healthcare: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2013 & 2020)
TABLE 3 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2012 – 2020 (USD Million)
TABLE 4 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2012 – 2020 (USD Million)
TABLE 5 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million)

Acute ischemic stroke can be defined as interruption of blood supply to the brain due to the blockage of blood vessel due to atherosclerosis plaques or blood clots in the artery. Acute ischemic stroke can caused due to thrombotic or embolic occlusion of cerebral artery. This research report on acute ischemia diagnosis and treatment market explains various advancements occurring in this market and analyzes the global acute ischemic stroke diagnosis and treatment market by diagnosis types and surgery types as well as geographic regions. This report comprises of an elaborate executive summary, which includes a market snapshot that provides a market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram which is drawn that reflects the market size of various segments in descending order.

The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnosis such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), ultrasound, cerebral angiography, nuclear imaging and others. The market for these diagnosis types has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the manufacturers. The market size and forecast in terms of USD million for each diagnosis type has been provided for the period 2012 to 2020. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each of the aforementioned market segment for the forecast period 2014 to 2020, considering 2013 as the base year.

In addition, the global market for acute ischemic stroke diagnosis and treatment is segmented based on the surgery types. The segment is categorized into carotid endarterectomy, angioplasty and endovascular mechanical thrombectomy. The market for these surgeries of acute ischemic stroke treatment has been extensively analyzed based on number of surgeries performed and cost of surgery. The market size and forecast in terms of USD million for each segment has been provided for the period 2012 to 2020. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2013 as the base year.

Geographically, the acute ischemic stroke diagnosis and treatment market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2012 to 2020 along with CAGR (%) for the forecast period 2014 to 2020. The research study also incorporates the competitive scenario of major players in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global acute ischemic stroke diagnosis and treatment market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis, and key players’ market share analysis in 2013 in the acute ischemic stroke diagnosis and treatment market. 

This research report also explains about value chain (distribution) analysis from the supplier of the raw material to the end-users (hospital, patient). One event impact analysis chart is also includes in this report that describe event and their impact associated with this market from 2012 to 2020. 

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report concludes with the profiles of major players in the acute ischemic stroke diagnosis and treatment market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes Covidien plc, Johnson and Johnson, Stryker Corporation, Abbott Laboratories, Hitachi Medical Corporation, GE healthcare, Penumbra, Inc. and Philips Healthcare.

The global acute ischemic stroke diagnosis and treatment market is segmented as follows:
  • Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type
    • Computed Tomography
    • Magnetic Resonance Imaging
    • Ultrasound
    • Cerebral Angiography
    • Nuclear Imaging
    • Others
  • Acute Ischemic Stroke Diagnosis and Treatment Market, by Surgery Type
    • Carotid Endarterectomy
    • Angioplasty
    • Endovascular Mechanical Thrombectomy
  • Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World


 
 
Back To Top